• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

A comprehensive review of the epidemiology and disease burden of Influenza B in nine European countries

tetano

Editor, Senior Moderator
Hum Vaccin Immunother. 2016 Feb 18:0. [Epub ahead of print]
[h=1]A comprehensive review of the epidemiology and disease burden of Influenza B in nine European countries.[/h] Tafalla M[SUP]1[/SUP], Buijssen M[SUP]2[/SUP], Geets R[SUP]1[/SUP], Vonk Noordegraaf-Schouten M[SUP]2[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] This review was undertaken to consolidate information on the epidemiology and burden of influenza B, as well as the circulation patterns of influenza B lineage in nine European countries. Following a comprehensive search of peer-reviewed and grey literature sources, we found that published data on influenza B epidemiology and burden are scarce. Surveillance data show frequent co-circulation of both influenza B lineages during influenza seasons, but little is known about its impact, especially in adults and the clinical burden of influenza B remains unknown. Mismatch between the circulating influenza B lineage and vaccine recommendations has been seen in at least one influenza season in every country. Such observations could impact the effectiveness of seasonal influenza vaccination programs using trivalent vaccines, which contain only one influenza B lineage (B/Yamagata or B/Victoria) and highlight the need for local studies to better understand the epidemiology and burden of influenza B in these countries.


[h=4]KEYWORDS:[/h] Europe; Influenza vaccine; co-circulation; influenza B; lineages; quadrivalent; trivalent; vaccine mismatch

PMID: 26890005 [PubMed - as supplied by publisher]
 
Back
Top Bottom